These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

442 related articles for article (PubMed ID: 20041351)

  • 1. Management of recurrent rectal cancer.
    Bouchard P; Efron J
    Ann Surg Oncol; 2010 May; 17(5):1343-56. PubMed ID: 20041351
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Locally recurrent rectal cancer: prognostic factors and long-term outcomes of multimodal therapy.
    Pacelli F; Tortorelli AP; Rosa F; Bossola M; Sanchez AM; Papa V; Valentini V; Doglietto GB
    Ann Surg Oncol; 2010 Jan; 17(1):152-62. PubMed ID: 19834766
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multidisciplinary approach to recurrent/unresectable rectal cancer: how to prepare for the extent of resection.
    Rodriguez-Bigas MA; Chang GJ; Skibber JM
    Surg Oncol Clin N Am; 2010 Oct; 19(4):847-59. PubMed ID: 20883958
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Treatment strategies for recurrent rectal cancer].
    Dietz S; Fritzmann J; Weidlich A; Schaser KD; Weitz J; Kirchberg J
    Chirurgie (Heidelb); 2024 Jun; 95(6):495-509. PubMed ID: 38739162
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Limitations of surgery for rectal cancer].
    Troja A; Petersen S; Antolovic D; Raab HR
    Chirurg; 2014 Mar; 85(3):192-7. PubMed ID: 24595476
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Surgery for locally recurrent rectal cancer in the era of total mesorectal excision: is there still a chance for cure?
    Rahbari NN; Ulrich AB; Bruckner T; Münter M; Nickles A; Contin P; Löffler T; Reissfelder C; Koch M; Büchler MW; Weitz J
    Ann Surg; 2011 Mar; 253(3):522-33. PubMed ID: 21209587
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patterns and prognosis of locally recurrent rectal cancer following multidisciplinary treatment.
    Zhao J; Du CZ; Sun YS; Gu J
    World J Gastroenterol; 2012 Dec; 18(47):7015-20. PubMed ID: 23323002
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic and predictive factors after surgical treatment for locally recurrent rectal cancer: a single institute experience.
    Asoglu O; Karanlik H; Muslumanoglu M; Igci A; Emek E; Ozmen V; Kecer M; Parlak M; Kapran Y
    Eur J Surg Oncol; 2007 Dec; 33(10):1199-206. PubMed ID: 17400423
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Excluding the ischiorectal fossa irradiation during neoadjuvant chemoradiotherapy with intensity-modulated radiotherapy followed by abdominoperineal resection decreases perineal complications in patients with lower rectal cancer.
    Song M; Geng J; Wang L; Li Y; Zhu X; Li X; Mi L; Wu A; Peng Y; Yao Y; Zhang Y; Wang H; Shi C; Cai Y; Wang W
    Radiat Oncol; 2019 Aug; 14(1):138. PubMed ID: 31382984
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical algorithms for the surgical management of locally recurrent rectal cancer.
    Mirnezami AH; Sagar PM; Kavanagh D; Witherspoon P; Lee P; Winter D
    Dis Colon Rectum; 2010 Sep; 53(9):1248-57. PubMed ID: 20706067
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessing pathological complete response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer: a systematic review.
    Ryan JE; Warrier SK; Lynch AC; Heriot AG
    Colorectal Dis; 2015 Oct; 17(10):849-61. PubMed ID: 26260213
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Surgery for recurrent rectal cancer: technical notes and management of complications.
    Mirnezami AH; Sagar PM
    Tech Coloproctol; 2010 Sep; 14(3):209-16. PubMed ID: 20461538
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A population-based study on the management and outcome in patients with locally recurrent rectal cancer.
    Palmer G; Martling A; Cedermark B; Holm T
    Ann Surg Oncol; 2007 Feb; 14(2):447-54. PubMed ID: 17139457
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment and survival of locally recurrent rectal cancer: A cross-sectional population study 15 years after the Dutch TME trial.
    Detering R; Karthaus EG; Borstlap WAA; Marijnen CAM; van de Velde CJH; Bemelman WA; Beets GL; Tanis PJ; Aalbers AGJ;
    Eur J Surg Oncol; 2019 Nov; 45(11):2059-2069. PubMed ID: 31230980
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic Significance of Neoadjuvant Rectal Score and Indication for Postoperative Adjuvant Therapy in Rectal Cancer Patients After Neoadjuvant Chemoradiotherapy.
    Maeda K; Shibutani M; Tachimori A; Nishii T; Aomatsu N; Fukuoka T; Nagahara H; Otani H; Inoue T; Ohira M
    In Vivo; 2020; 34(1):283-289. PubMed ID: 31882490
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Therapy of locally recurrent rectal carcinoma].
    Hempen HG; Raab HR
    Chirurg; 2009 Apr; 80(4):311-5. PubMed ID: 19350308
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative Outcomes of Neoadjuvant Treatment Prior to Total Mesorectal Excision and Total Mesorectal Excision Alone in Selected Stage II/III Low and Mid Rectal Cancer.
    Kulu Y; Tarantino I; Billeter AT; Diener MK; Schmidt T; Büchler MW; Ulrich A
    Ann Surg Oncol; 2016 Jan; 23(1):106-13. PubMed ID: 26305025
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chemoradiation with or without intraoperative radiation therapy in patients with locally recurrent rectal carcinoma: prognostic factors and long term outcome.
    Valentini V; Morganti AG; De Franco A; Coco C; Ratto C; Battista Doglietto G; Trodella L; Ziccarelli L; Picciocchi A; Cellini N
    Cancer; 1999 Dec; 86(12):2612-24. PubMed ID: 10594856
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of multimodal therapy in locally recurrent rectal cancer.
    You YN; Skibber JM; Hu CY; Crane CH; Das P; Kopetz ES; Eng C; Feig BW; Rodriguez-Bigas MA; Chang GJ
    Br J Surg; 2016 May; 103(6):753-762. PubMed ID: 26933792
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The potential predictive value of tumor budding for neoadjuvant chemoradiotherapy response in locally advanced rectal cancer.
    Jäger T; Neureiter D; Fallaha M; Schredl P; Kiesslich T; Urbas R; Klieser E; Holzinger J; Sedlmayer F; Emmanuel K; Dinnewitzer A
    Strahlenther Onkol; 2018 Nov; 194(11):991-1006. PubMed ID: 30069738
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.